Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. (DOVA) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 113 transactions totaling $32.4M, demonstrating a bullish sentiment with $30.6M in net insider flow. The most recent transaction on Nov 12, 2019 involved a transaction of 9,635 shares valued at $0.
DOVA Insider Activity Summary
Who Is Buying DOVA Stock?
No significant insider buying has been recorded for DOVA in the recent period.
Who Is Selling DOVA Stock?
No significant insider selling has been recorded for DOVA in the recent period.
Is Dova Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DOVA is bullish with an Insider Alignment Score of 97/100 and a net flow of $30.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
DOVA Frequently Asked Questions
Understanding DOVA Insider Activity
Insider trading at Dova Pharmaceuticals, Inc. (DOVA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading DOVA stock, having executed 113 transactions in the past 90 days. The most active insider is Paul B. Manning (Executive), who has made 21 transactions totaling $416.4M.
Related Tools
Track Dova Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at DOVA file new Form 4 transactions